close :

:

Forgotten your password?
 
FDA Drug Approvals
Printable Version   Email to a friend

Aricept ODT Eisai Inc. - Treatment for Alzheimer’s Disease

Aricept ODT is a new disintegrating tablet dosage form designed to make administration easier for patients with Alzheimer’s disease. Studies have shown these patients may develop difficulty with swallowing. Aricept ODT will be available in the U.S. in the second quarter of 2005.

Related Articles:

Eisai Submits Application to FDA for Aricept for Treatment of Severe Alzheimer's Disease - September 1, 2005

Latest FDA Drug Approvals...

FDA Drug Approvals Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

More News Resources